Login / Signup

A synthetic targeted RNA demethylation system based on CRISPR-Cas13b inhibits bladder cancer progression.

Ganglin SuLin YaoXiaohong HanXinhui LiaoJieqing ChenTao YinYing DongYanfeng LiKun HuJunwen XiaoYuchen LiuWeiren HuangHongbing Mei
Published in: Clinical and translational medicine (2022)
Keyphrases
  • crispr cas
  • genome editing
  • cancer therapy
  • nucleic acid
  • drug delivery